ZNF503 and glioblastoma: To evaluate the role of ZNF503-AS2 in GBM cells, we knocked down ZNF503-AS2 in GBM cell lines (LN229, U118 and A172) and primary GSCs (GBM#P3) using siRNAs, and the knockdown efficiency is shown in Fig 7A.